Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL S TANKERSLEY

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1114997814
CMS profile
737053
Location
COLLIERVILLE, TN

General Payments · PY2018–2024

$62,750.29

  • Reported across 458 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$665.90

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $643.38 33
Education $22.52 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $239.59 11
Acerta Pharma LLC $209.09 12
GlaxoSmithKline, LLC. $57.22 3
Genentech USA, Inc. $45.62 2
GENZYME CORPORATION $34.90 1
Hikma Pharmaceuticals USA $29.32 2
OptiNose US, Inc. $21.42 1
Merck Sharp & Dohme Corporation $15.24 1
LEO Pharma Inc. $13.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,215.15 54
PY2019 $14,861.25 82
PY2020 $17,744.30 66
PY2021 $6,896.46 85
PY2022 $19,614.74 103
PY2023 $752.49 34
PY2024 $665.90 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $14.71 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105577766 CMS
AstraZeneca Pharmaceuticals LP $18.35 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105682603 CMS
AstraZeneca Pharmaceuticals LP $14.88 06/10/2024 Food and Beverage Undisputed 01/23/2026 1104645445 CMS
AstraZeneca Pharmaceuticals LP $16.34 07/16/2024 Food and Beverage Undisputed 01/23/2026 1105460798 CMS
AstraZeneca Pharmaceuticals LP $17.46 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105432044 CMS
AstraZeneca Pharmaceuticals LP $21.42 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105626177 CMS
AstraZeneca Pharmaceuticals LP $13.82 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104575152 CMS
AstraZeneca Pharmaceuticals LP $19.20 10/01/2024 Food and Beverage Undisputed 01/23/2026 1104498474 CMS
AstraZeneca Pharmaceuticals LP $16.34 10/31/2024 Food and Beverage Undisputed 01/23/2026 1105746725 CMS
AstraZeneca Pharmaceuticals LP $22.52 11/11/2024 Education Undisputed 01/23/2026 1104255869 CMS
AstraZeneca Pharmaceuticals LP $16.46 12/03/2024 Food and Beverage Undisputed 01/23/2026 1104557384 CMS
AstraZeneca Pharmaceuticals LP $17.59 12/12/2024 Food and Beverage Undisputed 01/23/2026 1105567700 CMS
Genentech USA, Inc. $23.50 03/05/2024 Food and Beverage Undisputed 01/23/2026 1133071704 CMS
Genentech USA, Inc. $22.12 05/07/2024 Food and Beverage Undisputed 01/23/2026 1133071700 CMS
GENZYME CORPORATION $34.90 06/04/2024 Food and Beverage Undisputed 01/23/2026 1139655991 CMS
GlaxoSmithKline, LLC. $20.50 04/09/2024 Food and Beverage Undisputed 01/23/2026 1116450257 CMS
GlaxoSmithKline, LLC. $18.16 09/09/2024 Food and Beverage Undisputed 01/23/2026 1116093772 CMS
GlaxoSmithKline, LLC. $18.56 09/20/2024 Food and Beverage Undisputed 01/23/2026 1116172175 CMS
Hikma Pharmaceuticals USA $15.21 03/25/2024 Food and Beverage Undisputed 01/23/2026 1127505664 CMS
Hikma Pharmaceuticals USA $14.11 07/23/2024 Food and Beverage Undisputed 01/23/2026 1127505706 CMS
LEO Pharma Inc. $13.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 1152653489 CMS
Merck Sharp & Dohme LLC $15.24 06/18/2024 Food and Beverage Undisputed 01/23/2026 1141612260 CMS
Optinose US, Inc. $21.42 10/03/2024 Food and Beverage Undisputed 01/23/2026 1142187500 CMS
PFIZER INC. $20.90 01/02/2024 Food and Beverage Undisputed 01/23/2026 1130956443 CMS
PFIZER INC. $24.01 02/07/2024 Food and Beverage Undisputed 01/23/2026 1131072221 CMS
PFIZER INC. $19.79 03/05/2024 Food and Beverage Undisputed 01/23/2026 1131257984 CMS
PFIZER INC. $22.92 04/03/2024 Food and Beverage Undisputed 01/23/2026 1131385737 CMS
PFIZER INC. $11.32 05/01/2024 Food and Beverage Undisputed 01/23/2026 1131723816 CMS
PFIZER INC. $27.48 06/05/2024 Food and Beverage Undisputed 01/23/2026 1131667315 CMS
PFIZER INC. $24.07 07/03/2024 Food and Beverage Undisputed 01/23/2026 1131780210 CMS
PFIZER INC. $22.68 08/07/2024 Food and Beverage Undisputed 01/23/2026 1131867618 CMS
PFIZER INC. $24.06 09/04/2024 Food and Beverage Undisputed 01/23/2026 1131959769 CMS
PFIZER INC. $21.24 10/08/2024 Food and Beverage Undisputed 01/23/2026 1130890137 CMS
PFIZER INC. $21.12 12/10/2024 Food and Beverage Undisputed 01/23/2026 1131038084 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.